Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre Hospitalier Annecy Genevois, Annecy, Epagny Metz-Tessy, France
Contact: Principal Investigator (Aude Montchaud)CHU Amiens, Amiens, France
Contact: Principal Investigator (Vincent HAUTEFEUILLE)Institut régional du cancer Provence d'Avignon, Avignon, France
Contact: Principal Investigator (May MABRO)Centre Hospitalier de la Côte Basque, Bayonne, France
Contact: Principal Investigator (Franck Audemar)CHU Besançon, Besançon, France
Contact: Principal Investigator (Angélique VIENOT)CH Béthune et Beuvry, Beuvry, France
Contact: Principal Investigator (Hélène VAN DAMME)ICHF Centre Pierre Curie, Beuvry, France
Contact: Principal Investigator (BASSON Laurent)CHRU Brest, Brest, France
Contact: Principal Investigator (Jean-Philippes METGES)Centre François Baclesse, Caen, France
Contact: Principal Investigator (Aurélie PARZY)CHU Clermont-Ferrand, Clermont-Ferrand, France
Contact: Study coordinator (Lise LACLAUTRE)Contact: Study coordinator (Lise Laclautre) · promo_interne_drci@chu-clermontferrand.fr · 0473754963Contact: Principal Investigator (Marine JARY)CHU Dijon, Dijon, France
Contact: Principal Investigator (Sylvain MANFREDI)Groupe Hospitalier Mutualiste, Grenoble, France
Contact: Principal Investigator (Hélène FLESCH)CHRU Lille, Lille, France
Contact: Principal Investigator (Anthony TURPIN)CHU Limoges, Limoges, France
Contact: Principal Investigator (Frédéric THUILLIER)Centre Léon BERARD de Lyon, Lyon, France
Contact: Principal Investigator (Clélia COUTZAC)CHU Nancy, Nancy, France
Contact: Principal Investigator (Marie MULLER)Hôpital Européen Georges-Pompidou, Paris, France
Contact: Principal Investigator (Aziz ZANAAN)Hôpital Saint-Louis Lariboisière, Paris, France
Contact: Principal Investigator (Thomas APARICIO)Le Groupe Hospitalier Diaconesses Croix Saint-Simon de Paris, Paris, France
Contact: Principal Investigator (Olivier DUBREUIL)Centre hospitalier de Perpignan, Perpignan, France
Contact: Principal Investigator (Faiza KHEMISSA AKOUZ)CHU Poitiers, Poitiers, France
Contact: Principal Investigator (David TOUGERON)Centre Régional du Lutte Contre Le Cancer - Institut Godinot, Reims, France
Contact: Principal Investigator (Damien BOTSEN)CHU de Reims, Reims, France
Contact: Principal Investigator (Olivier BOUCHE)CHU Rennes, Rennes, France
Contact: Principal Investigator (Astrid LIEVRE)CHU Rouen, Rouen, France
Contact: Principal Investigator (Frédéric DI FIORE)Institut de Cancérologie de l'Ouest, Saint-Herblain, France
Contact: Principal Investigator (Judith RAIMBOURG)Groupe Hospitalier Rance Emeraude, St-Malo, France
Contact: Principal Investigator (Anaïs BODERE)Institut Public de Cancérologie Strauss Europe,, Strasbourg, France
Contact: Principal Investigator (Meher BEN ABDELGHANI)CHRU Tours, Tours, France
Contact: Principal Investigator (Thierry LECOMTE)Médipôle Hôpital Mutualiste, Villeurbanne, France
Contact: Principal Investigator (Matthieu SARABI)